valsartan has been researched along with Congenitally Corrected Transposition in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fusco, F; Grimaldi, N; Iannuzzi, A; Merola, A; Palma, M; Sarubbi, B; Scognamiglio, G | 1 |
1 other study(ies) available for valsartan and Congenitally Corrected Transposition
| Article | Year |
|---|---|
Safety and Efficacy of Sacubitril/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Congenitally Corrected Transposition of the Great Arteries; Drug Combinations; Female; Heart Failure; Heart Ventricles; Humans; Male; Prospective Studies; Quality of Life; Stroke Volume; Tetrazoles; Transposition of Great Vessels; Valsartan | 2023 |